These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17227707)

  • 1. Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB.
    Levaux MN; Potvin S; Sepehry AA; Sablier J; Mendrek A; Stip E
    Eur Psychiatry; 2007 Mar; 22(2):104-15. PubMed ID: 17227707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact of electroconvulsive therapy on visual and visuospatial memory.
    Falconer DW; Cleland J; Fielding S; Reid IC
    Psychol Med; 2010 Jun; 40(6):1017-25. PubMed ID: 19775495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An optimal combination of MCCB and CANTAB to assess functional capacity in older individuals with schizophrenia.
    Kumar S; Mulsant BH; Tsoutsoulas C; Ghazala Z; Voineskos AN; Bowie CR; Rajji TK
    Int J Geriatr Psychiatry; 2016 Oct; 31(10):1116-23. PubMed ID: 27428251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition.
    Kanchanatawan B; Thika S; Anderson G; Galecki P; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):168-176. PubMed ID: 28666826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General and social cognition in first episode schizophrenia: identification of separable factors and prediction of functional outcome using the IntegNeuro test battery.
    Williams LM; Whitford TJ; Flynn G; Wong W; Liddell BJ; Silverstein S; Galletly C; Harris AW; Gordon E
    Schizophr Res; 2008 Feb; 99(1-3):182-91. PubMed ID: 18053688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the Cambridge Automated Neuropsychological Test Battery (CANTAB) Distinguish Between Cognitive Domains in Healthy Older Adults?
    Lenehan ME; Summers MJ; Saunders NL; Summers JJ; Vickers JC
    Assessment; 2016 Apr; 23(2):163-72. PubMed ID: 25882162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The detection of neurocognitive decline in schizophrenia using the Mindstreams Computerized Cognitive Test Battery.
    Ritsner MS; Blumenkrantz H; Dubinsky T; Dwolatzky T
    Schizophr Res; 2006 Feb; 82(1):39-49. PubMed ID: 16377157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal consistency and stability of the CANTAB neuropsychological test battery in children.
    Syväoja HJ; Tammelin TH; Ahonen T; Räsänen P; Tolvanen A; Kankaanpää A; Kantomaa MT
    Psychol Assess; 2015 Jun; 27(2):698-709. PubMed ID: 25528164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcome.
    Rodriguez-Toscano E; López G; Mayoral M; Lewis S; Lees J; Drake R; Arango C; Rapado-Castro M
    Schizophr Res; 2020 Feb; 216():347-356. PubMed ID: 31813804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cognitive functions in animal models of schizophrenia.
    Nikiforuk A
    Pharmacol Rep; 2018 Aug; 70(4):639-649. PubMed ID: 29894866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measuring the cognitive deficit associated with schizophrenia: presentation of the MATRICS neuropsychological test battery].
    Sarolta K; Pál C; István B
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):143-50. PubMed ID: 18399033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia].
    Jedrasik-Styła M; Ciołkiewicz A; Denisiuk M; Linke M; Parnowska D; Gruszka A; Jarema M; Wichniak A
    Psychiatr Pol; 2012; 46(2):261-71. PubMed ID: 23214396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
    Nuechterlein KH; Green MF; Kern RS; Baade LE; Barch DM; Cohen JD; Essock S; Fenton WS; Frese FJ; Gold JM; Goldberg T; Heaton RK; Keefe RS; Kraemer H; Mesholam-Gately R; Seidman LJ; Stover E; Weinberger DR; Young AS; Zalcman S; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):203-13. PubMed ID: 18172019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMINDS does not have identical tests to the CATIE and MATRICS batteries. Commentary on O'Halloran et al.
    Kern RS; Green MF; Nuechterlein KH; Keefe RS
    Schizophr Res; 2009 Feb; 107(2-3):327-9; author reply 330-1. PubMed ID: 19013770
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuropsychological profile in early-onset schizophrenia-spectrum disorders: measured with the MATRICS battery.
    Holmén A; Juuhl-Langseth M; Thormodsen R; Melle I; Rund BR
    Schizophr Bull; 2010 Jul; 36(4):852-9. PubMed ID: 19223656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assessed cognitive dysfunction and objective performance in outpatients with schizophrenia participating in a rehabilitation program.
    Prouteau A; Verdoux H; Briand C; Lesage A; Lalonde P; Nicole L; Reinharz D; Stip E
    Schizophr Res; 2004 Jul; 69(1):85-91. PubMed ID: 15145474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
    Bozikas VP; Kosmidis MH; Giannakou M; Anezoulaki D; Petrikis P; Fokas K; Karavatos A
    J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontal-striatal cognitive deficits in patients with chronic schizophrenia.
    Pantelis C; Barnes TR; Nelson HE; Tanner S; Weatherley L; Owen AM; Robbins TW
    Brain; 1997 Oct; 120 ( Pt 10)():1823-43. PubMed ID: 9365373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of Cognitive Impairment in Schizophrenia: Reliability, Sensitivity, and Specificity of the Repeatable Battery for the Assessment of Neuropsychological Status in a Spanish Sample.
    De la Torre GG; Perez MJ; Ramallo MA; Randolph C; González-Villegas MB
    Assessment; 2016 Apr; 23(2):221-31. PubMed ID: 25934161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.